Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials.

Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials. — المؤلف: Verma, Subodh — Diabetes, obesity & metabolism 20200710

المؤلف
Verma, Subodh
النشر
Diabetes, obesity & metabolism 20200710
الوصف
1745-1751 p.
الموضوعات
Aged؛ Cardiovascular Diseases؛ Diabetes Mellitus, Type 2؛ Female؛ Glucagon-Like Peptides؛ Humans؛ Hypoglycemic Agents؛ Kidney Diseases